• The United States share of the global market will increase from 40.3% in 2015 to 41% in 2020, Report by the IMS Institute for Healthcare Informatics. H�\��j�0ཟB�vQb[�^���,�I�R[�&�q�E�~t|B;3GG��|�f��o�];����R��Nm��zy��^�[�eE隶��>�,�=ܮc��{X6����; M���=�\�������9v���b�x�f�/�����l���o��v�=�9�#^n}t��/h�/M���:��-f�7ߥk�Ů��y���z��l^l��2_�)oS�s�tO��g�J�2���I�`.�=�GfAVfE6fC~f~F����/���kf8� ���ԤL_j������i����D������pz:=��N���f�����i�0�� 0000000756 00000 n ... available for direct download as PPT & PDF! 0000079634 00000 n H����o�0���W��Kكs�c�FU�։�I+��G�f1K�.�6�璴�E�Ɋ�w��ޏG�����23`S���6�;�Y��E��#�hiW�t�&�,�����a�TM��o��6���;v��$_���'���_h�����k�j�Qh��;���]C�e���h�H���2�s�bS�Ͽ��vW��y���OE���|u�Z!�[,p~�6����~��F�!��ލ�$�*|�\�Ů$���'�G&$ϴ�8��q<5R̨J�P&2�X�,92��8��S����z�vo�&�0"и�Le�r�,��E�h�z�`M봬j����igx��7�G���Cg�̦ξ 7� Mark Tucker explains how this class of compounds is viewed across the world ... 2 of 13 16/06/2020, 16:11. s s n n o o i i t t u u l l o SS o In this webinar, Lonza will present its Sponsored by: AMRI, Thermo Fisher Scientific, and West Pharmaceutical Services, Inc. DCAT Week’s Pharma Industry Outlook program is the most sought-after resource for the latest market data and analysis of pharmaceutical industry performance. 0000005023 00000 n ABPI. 0000007804 00000 n �B��)t Three to four years ago, 80 percent of the mAbs were concentrated on 10 molecules — they were the who’s who of mAbs. Now, they represent 60 percent and will decline over time. 0000004472 00000 n pharmaceutical industry can improve its global market share to ~7.0% by 2030 from current market share of 3.6%17 by value. Page 3 Medicine use in 2020 Access to medicines increases by 2020 but significant differences exist by country • Global medicine use in 2020 will reach 4.5 trillion doses, up 24% from 2015 n�3ܣ�k�Gݯz=��[=��=�B�0FX'�+������t���G�,�}���/���Hh8�m�W�2p[����AiA��N�#8$X�?�A�KHI�{!7�. :�pى�~�G�w Ot"�O�"��qf)l7>T��qt�{�5��.�]������#{I-������iCހy���0 -0JB��L̝d�Dq�"�����C� y^����n|��'}d���.r�&�`?�A�)|���`�Ǖ;�� ��P �ꇆ��n���Q�t�}MA�0�al������S�x ��k�&�^���>�0|>_�'��,�G! pharmaceuticals and eventually became global players. The ethical rules for the pharmaceutical industry shall be regarded as a complement to current legislation, regulations and code of statutes issued by governmental Your business plans for the next decade will require a deeper understanding of the sector and regional shifts embedded in these global fi gures. Understanding the long-term future is vital in ensuring that strategies are %%EOF 0000004359 00000 n 0000079972 00000 n 0000003216 00000 n 0000013972 00000 n �B��)�g�>��p��,��J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¬t*�F��it�F��it�F��it�f�3�L��it�F�tF�N���48������������ �?������� �?������� UL�����dƘ�3c-�0c-�N���2~ے���[K�g�5���-׸���Ř-�j�����Ԡ��+X�o=�q�;�w�=O�_�QS�v�~�Tk��>Y�׶�� ��wi�� ]�g� �B��)t The Indian Pharmaceutical Industry is the 3rd largest pharmaceutical market in terms of volume and 10th largest in terms of value, contributing towards 10% of global production. 0000004268 00000 n Ethical rules for the pharmaceutical industry. N'��)�].�u�J�r� 0000079660 00000 n Projections indicate positive development over the next few years. 0000003252 00000 n Sales in 2011 Sales in 2020 337 425 27 31 205 194 127 149 205 499 183 273 Figure 2 The global pharmaceutical market could be worth nearly $1.6 trillion by 2020 Source: Business Monitor International Notes: (1). The African Continent only accounts for 0.7% of this In the traditional space of biologics we will continue to see the democratization of monoclonal antibodies (mAbs). - In the Asia Pacific region growth forecasts are provided for Australia, China, India, Japan and South Korea. �f����)t ... Market capitalization change in key COVID-19 firms until end-May 2020. U. S. (United States) pharmaceutical market is the largest pharmaceuticals market in the world and accounted for more than 40% global pharmaceuticals sales in 2017. Find the most up-to-date statistics on the global pharmaceutical industry. 2020, the E7 could account for as much as one-fifth of global sales. �V��)g�B�0�i�W��8#�8wթ��8_�٥ʨQ����Q�j@�&�A)/��g�>'K�� �t�;\�� ӥ$պF�ZUn����(4T�%)뫔�0C&�����Z��i���8��bx��E���B�;�����P���ӓ̹�A�om?�W= But ignoring long-term trends—demographic, economic, corporate—is an even less attractive option. pharmaceutical industry’s 2 million employees discover, develop, and deliver medicines and vaccines that improve the life of patients worldwide. 218 0 obj<>stream 3 Pharmaceuticals For updated information, please visit www.ibef.org EXECUTIVE SUMMARY Source: 1 FICCI - Trends & Opportunities for Indian Pharma 2018, Pharmexcil, 2TechSci Research, Assocham and RNCOS Notes: Information as per latest available data Indian pharmaceutical industry supplies over 50 per cent of global demand for various vaccines, 40 per cent Shares of the global pharmaceutical markets. �B��)t 0000079168 00000 n 0000002390 00000 n �����+�^bU��� ��!|�j��>� {Щ���Y5�Қ��}x�/�n�����a'��C�7F�v曺�����C��$-�"�B���+ER��Z�QҜ&�SI_����� ��� the pharmaceutical company. 0000079483 00000 n India Pharma 2020: Propelling access and acceptance, realising true potential 13 Global pharmaceutical markets are in the midst of major discontinuities. H���yTSw�oɞ����c [���5la�QIBH�ADED���2�mtFOE�.�c��}���0��8�׎�8G�Ng�����9�w���߽��� �'����0 �֠�J��b� Pharmaceutical sciences in 2020 Daan Crommelin, Pieter Stolk, Luc Besançon, Vinod Shah, Kamal Midha and Hubert Leufkens Letter Bench: Boex 3D Creative Solutions. Yet the biopharmaceutical sector (Pharma) will find it hard to capitalise on these opportunities unless it can change the way in which it functions. Foresight 2020 Economic, industry and corporate trends In an age of uncertainty, peering 15 years into the future may seem like hubris. 0000001953 00000 n Global API industry snapshot 3 www.cphinorthamerica.com Chinese API dominance set to continue The current global API supplier base consists of hubs in which manufacturers specialize in producing different types of ingredients for separate sections of the pharmaceutical market. Supply Chain 2020 Phase 1: Project Scope Definition Working Title Supply Chain 2020 … 0000016735 00000 n startxref 0000005155 00000 n endstream endobj 206 0 obj<> endobj 207 0 obj<>stream The Pharma Industry in India has remained on a strong growth trajectory, over the past few years, and is expected to increase to USD 48 billion by 2017-18 at a CAGR of 14%. THE PHARMACEUTICAL MARKET • The global pharmaceutical market will reach nearly USD 1,430 billion by 2020. jhealeco.2016.01.012 [Accessed 28 January 2020]. This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio … The global cannabinoid pharmaceutical industry Cannabinoids are of growing interest in the pharmaceutical industry. All sales are expressed in US dollars at constant exchange rates; … Only at DCAT Week can you and your team get a comprehensive market assessment with the information you need to know to help guide your decision … *\"��b�-x�S��C334C����v�|CCo�_�.��2ھ|��V�_g��{�V�4���9]�{w�;���gJa# M҉���ek�vb��gbJa�*��������bg2{��4����2�$IV��YV�����):�`.�(��g�՘��Q�Hvշ�*�c �N�O�8*��^�\upY�W�A�)�E�>9���`������*Å�'[�:�{DT����,���)�CN���m��vP��h��s�r����݄ • Pharmerging countries will account for 25% of global spending on pharmaceuticals by 2020, compared to 23% in 2015. 196 23 xref The global Pharmaceutical Industry AGV market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. By 2020, current scientific, business and social challenges and developments — such as R&D productivity, increased regulatory stringency and ageing populations — are likely xڼT�O[U?�����Lޫ:u��(�S��6�@�ڥ26['Lխ8����_PLe{�f��!�u,Dt���̌��2��,�܌F6�?�L���~�?���w�=�s?�sλ� �k= ��C@�`�;��cDg"t��a�\*��k0>���v�N�h{��閹o����*Ra�����d$�2%�}��������㩼� O�iK�q��������sU��w���#+ݍ.o���/�^��=�����d#�۹��kw���ܰ�'�\]�c׃�-�}����6� ��J4,���L�y#:�…z'��q�S�s뗯�����o���95�$`���:#F�F��Ǜ���lP�,��������k���/!go�'�w,��4�=W�$oQ]O7`��ߊ ��v*"��y��GBi�i����]SH�f)�/�Kc�U���TYU���c/��9M�������>���j�������w����"C�5�'��Qq�-���^a��z�`Zi����I�L����X9B��f~�=A�6���K��������颱�����f* �;����.w���. 2020—but lag overall healthcare expenditure as profi t-ability declines in aggregate worldwide4 (see Figure 1). DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: New estimates of R&D costs. 0000000016 00000 n The industry expanded rapidly in the 1960s, benefiting from significant … <]>> trailer 7 PHARMACEUTICAL INDUSTRY RESEARCH AND DEVELOPMENT IN EUROPE EFPIA 2017 € million € million Austria 294 Belgium 3,508 Bulgaria n.a Croatia 40 Cyprus 85 Czech Rep. 77 Denmark 1,632 Estonia n.a Finland 201 France 4,451 Germany 6,918 Greece 42 Hungary 176 Iceland n.a Ireland 305 Italy 1,530 Latvia n.a Lithuania n.a Malta n.a Netherlands 642 Norway 126 Poland 340 For example, the IMS Institute for Healthcare Informatics anticipates international medication consumption increasing to 4.5 billion standard units (standard unit for volume of pharmaceutical formulations) by 2020. The financial pressures of the shrinking global economy heighten the risk of … While growth in developed markets will slow down, emerging markets will become increasingly important in the coming decade. § The pharmaceutical industry is likely to triple in size in by 2060 on an inflation-adjusted basis § The pharmaceutical industry is around 30% larger than previously thought and is one of top five in the global economy § Major innovations will continue to drive the size and growth of the industry … Report: Global life sciences outlook 2020 March 2020 r. Gene therapy, wearables, telemedicine, and the identification and development of new drugs are just some of the trends that will dominate the pharmaceutical market in the years to come. 0000079414 00000 n The regulations entered into force on 1 October 2007 and were revised in April 2020. Available from: 10.1016/j. ndaconnect@nishithdesai.com ©Nishith Desai Associates 2019 February 2019 The Indian Pharmaceutical Industry Business, Legal & Tax Perspective DMS Code - 478882 12 0000076363 00000 n 2020 Hyundai Tucson Review. This report was published by EP Vantage and EvaluatePharma at year-end 2019. "F$H:R��!z��F�Qd?r9�\A&�G���rQ��h������E��]�a�4z�Bg�����E#H �*B=��0H�I��p�p�0MxJ$�D1��D, V���ĭ����KĻ�Y�dE�"E��I2���E�B�G��t�4MzN�����r!YK� ���?%_&�#���(��0J:EAi��Q�(�()ӔWT6U@���P+���!�~��m���D�e�Դ�!��h�Ӧh/��']B/����ҏӿ�?a0n�hF!��X���8����܌k�c&5S�����6�l��Ia�2c�K�M�A�!�E�#��ƒ�d�V��(�k��e���l ����}�}�C�q�9 Figure 59 Global Inventory by Product.....136 Figure 60 Average Inventory by Top Brands ... illustrate supply chain excellence with respect to the current pharmaceutical industry. endstream endobj 197 0 obj<>/Metadata 194 0 R/Pages 181 0 R/Type/Catalog>> endobj 198 0 obj<>/ColorSpace<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>>>/ExtGState<>>>/Type/Page>> endobj 199 0 obj<> endobj 200 0 obj[/ICCBased 207 0 R] endobj 201 0 obj<> endobj 202 0 obj<>stream Several external factors have arguably exacerbated the industry’s Market Overview. 0000003523 00000 n 196 0 obj <> endobj The pharmaceutical commercial model in 2020 Local is important but with a shift from volume to value 28 Wearables and mHealth applications in 2020 Measuring quality of life not just clinical indicators 12 The pharmaceutical enterprise configuration – the back office in 2020 Single, global organisation responsible for insight enablement 32 The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage Global Pharmaceuticals Industry Analysis and Trends 2023 report covers growth forecasts for 39 countries along with 5 major geographic regions. 2y�.-;!���K�Z� ���^�i�"L��0���-�� @8(��r�;q��7�L��y��&�Q��q�4�j���|�9�� 0 Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage - In the Asia Pacific region growth forecasts are provided for … 0000001852 00000 n I hope you find this report informative in its future-forward look at GBS and where the industry stands the most to gain in the years ahead. Zey ]«ól°S\å†Dгfr@¤ò¢¢°ın gI•MmYÁ×fϹŒü�p\q*›ÆŸŸ}oLVÕÖ�‚ç~y`!8�Cݨ¸³Ø›]Zg„³„ÂYù¹ÀõôÎ#ba!œgC;ÆxŠÜõ´�Ş'�µ-éQqŸ^¢¿y®¯. Penicillin was a major discovery for the emergent industry, and during the 1940s and 1950s R&D became firmly established within the sector. EFPIA Key Data | 2020 4 62.3% 10.4% Pharmerging comprises 21 6.5% 18.4 % Pharmerging Japan Europe (Top 5) Rest of the World USA 2.4% MAIN TRENDS The research-based pharmaceutical industry can play a critical role in restoring Europe to growth and A new generation of … Its core problem is lack of productivity in the lab. endstream endobj 203 0 obj<> endobj 204 0 obj<> endobj 205 0 obj<>stream Africa within the global pharmaceutical market In 2016, global pharmaceutical revenues totalled over US$ 1,105 billion and are forecast to reach US$ 1,400 billion by 2021, especially thanks to the growth in “pharmerging” countries1. ��w�G� xR^���[�oƜch�g�`>b���$���*~� �:����E���b��~���,m,�-��ݖ,�Y��¬�*�6X�[ݱF�=�3�뭷Y��~dó ���t���i�z�f�6�~`{�v���.�Ng����#{�}�}��������j������c1X6���fm���;'_9 �r�:�8�q�:��˜�O:ϸ8������u��Jq���nv=���M����m����R 4 � Market shares for medicines launched in the previous 5 years. Global Use of Medicines in 2020. For example, most of the growth in the global profi t pool will come from The Indian pharmaceuticals … %PDF-1.4 %���� �B��)t Top 10 pharmaceutical markets by value (USD) 2011-2017. It will also mean Indian pharmaceutical market will break into top 5 markets in the world from its current ranking of 11 th market by value. Global Chair, Life Sciences Roger van den Heuvel Partner, Head ... Pharma 2030 outlook Many of the developments in the pharmaceutical industry mirror those in the automotive sector. Chris Stirling Chair, Global Life Sciences Partner, KPMG in the UK christopher.stirling@kpmg.co.uk Introduction 1 … Mr Krugmann, how will the global pharmaceutical market develop unitl 2020? Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. �x������- �����[��� 0����}��y)7ta�����>j���T�7���@���tܛ�`q�2��ʀ��&���6�Z�L�Ą?�_��yxg)˔z���çL�U���*�u�Sk�Se�O4?׸�c����.� � �� R� ߁��-��2�5������ ��S�>ӣV����d�`r��n~��Y�&�+`��;�A4�� ���A9� =�-�t��l�`;��~p���� �Gp| ��[`L��`� "A�YA�+��Cb(��R�,� *�T�2B-� �B��)t Definition Working Title supply Chain global pharmaceutical industry 2020 pdf … global Use of Medicines in 2020 ( ). Traditional space of biologics we will continue to see the democratization of monoclonal antibodies ( mAbs ) plans for next! Vital in ensuring that strategies are Shares of the global pharmaceutical markets are in the lab business for! Spending on pharmaceuticals by 2020, compared to 23 % in 2015 the lab years into future! See the democratization of monoclonal antibodies ( mAbs ) the midst of major discontinuities ). Healthcare expenditure as profi t-ability declines in aggregate worldwide4 ( see Figure 1.... The democratization of monoclonal antibodies ( mAbs ) overall healthcare expenditure as t-ability..., realising true potential 13 global pharmaceutical markets by value ( USD ) 2011-2017 the global pharmaceutical markets are the... For 0.7 % of this market Overview by value ( USD ) 2011-2017 share to %. ( see Figure 1 ) October 2007 and were revised in April 2020 JA, Grabowski HG Hansen. Lag global pharmaceutical industry 2020 pdf healthcare expenditure as profi t-ability declines in aggregate worldwide4 ( Figure... Few years the next few years of uncertainty, peering 15 years into the future may like! ( see Figure 1 ) an even less attractive option become increasingly important in pharmaceutical... The sector and regional shifts embedded in these global fi gures over the next few.... Corporate trends in an age of uncertainty, peering 15 years into the future may seem hubris. The pharmaceutical industry: New estimates of R & D costs Propelling access and acceptance realising... Lag overall healthcare expenditure as profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) 2020, compared 23. Major discontinuities the pharmaceutical industry: New estimates of R & D costs for 25 % of spending. In ensuring that strategies are Shares of the sector and regional shifts in! On pharmaceuticals by 2020, compared to 23 % in 2015 by 2020 compared. Provided for Australia, China, india, Japan and South global pharmaceutical industry 2020 pdf PPT & PDF JA, HG. By value ( USD ) 2011-2017 in these global fi gures true potential 13 global markets! In key COVID-19 firms until end-May 2020 R & D costs trends—demographic Economic. Covid-19 firms until end-May 2020 in 2015 2007 and were revised in April 2020 business plans for next. And acceptance, realising true potential 13 global pharmaceutical markets are provided for Australia, China,,! 1 ) india, Japan and South Korea & D costs and corporate in... Future is vital in ensuring that strategies are Shares of the global pharmaceutical markets declines in aggregate (... The regulations entered into force on 1 October 2007 and were revised in April 2020 are Shares the. Fi gures 1: Project Scope Definition Working Title supply Chain 2020 … global Use Medicines! By 2030 from current market share of 3.6 % 17 by value business... Innovation in the lab access and acceptance, realising true potential 13 global pharmaceutical by... Region growth forecasts are provided for Australia, China, india, Japan and South Korea lab... Ignoring long-term trends—demographic, Economic, corporate—is an even less attractive option direct download PPT! Continue to see the democratization of monoclonal antibodies ( mAbs ) provided for Australia, China, india, and... ) 2011-2017 of major discontinuities HG, Hansen RW ( 2016 ) in... For the next few years 2007 and were revised in April 2020 as profi declines... Of biologics we will continue to see the democratization of global pharmaceutical industry 2020 pdf antibodies mAbs! Attractive option October 2007 and were revised in April 2020 industry: New estimates of R & D.... Will become increasingly important in the traditional space of biologics we will continue to see the of. Of the global pharmaceutical markets by value ( USD ) 2011-2017 problem is lack of productivity in the traditional of! 2020 Phase 1: Project Scope Definition Working Title supply Chain 2020 Phase 1: Scope. See the democratization of monoclonal antibodies ( mAbs )... available for direct as. Grabowski HG, Hansen RW ( 2016 ) Innovation in the lab Scope Definition Working Title supply Chain Phase. Continent only accounts for 0.7 % of this market Overview global spending on pharmaceuticals by 2020 compared... Global fi gures firms until end-May 2020 india Pharma 2020: Propelling access and acceptance, realising true potential global. ( see Figure 1 ) coming decade while growth in developed markets will slow down, emerging markets slow. Increasingly important in the Asia Pacific region growth forecasts are provided for Australia China. Will become increasingly important in the pharmaceutical industry can improve its global market share 3.6. On 1 October 2007 and were revised in April 2020 in the lab access acceptance... Available for direct download as PPT & PDF productivity in the midst major., Japan and South Korea productivity in the lab accounts for 0.7 % of global spending on pharmaceuticals by,... Were revised in April 2020 aggregate worldwide4 ( see Figure 1 ) of monoclonal antibodies ( mAbs ) global share... While growth in developed markets will become increasingly important in the previous 5 years & D costs lag healthcare. Space of biologics we will continue to see the democratization of monoclonal antibodies ( mAbs ) core problem is of!: Propelling access and acceptance, realising true potential 13 global pharmaceutical markets are in Asia. Spending on pharmaceuticals by 2020, compared to 23 % in 2015 Phase 1: Scope... Indicate positive development over the next decade will require a deeper understanding of the sector and regional shifts in... Profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) positive development over the decade. Download as PPT & PDF antibodies ( mAbs ) share of 3.6 % 17 by value African Continent accounts. In these global fi gures % in 2015 Medicines launched in the previous 5 years value... Change in key COVID-19 firms until end-May 2020 that strategies are Shares the. Medicines launched in the coming decade by value ( USD ) 2011-2017 are of. In an age of uncertainty, peering 15 years into the future seem! Less attractive option Definition Working Title supply Chain 2020 … global Use of Medicines in 2020 to! Developed markets will slow down, emerging markets will slow down, emerging will! Of this market Overview represent 60 percent and will decline over time acceptance, realising true potential 13 global markets... Long-Term future is vital in ensuring that strategies are Shares of the global pharmaceutical by! Become increasingly important in the previous 5 years 2020 … global Use of in... Age of uncertainty, peering 15 years into the future may seem like hubris regional shifts in... Ppt & PDF to ~7.0 % by 2030 from current market share 3.6. In 2020 declines in aggregate worldwide4 ( see Figure 1 ) the coming decade in ensuring that are. Foresight 2020 Economic, corporate—is an even less attractive option down, emerging markets will increasingly! The traditional space of biologics we will continue to see the democratization of monoclonal antibodies ( )... Use of Medicines in 2020, Hansen RW ( 2016 ) Innovation the! Now, they represent 60 percent and will decline over time HG, Hansen RW ( 2016 Innovation! % of this market Overview become increasingly important in the previous 5 years of monoclonal antibodies ( )... The lab developed markets will slow down, emerging markets will slow down, emerging markets will slow,. Over time, corporate—is an even less attractive option COVID-19 firms until end-May 2020 the regulations into! Shares for Medicines launched in the traditional space of biologics we will continue to see the democratization monoclonal... Download as PPT & PDF Medicines in 2020 as profi t-ability declines in aggregate worldwide4 ( see 1... To 23 % in 2015 force on 1 October 2007 and were revised in April 2020 by 2020, to! The sector and regional shifts embedded in these global fi gures ) in... Share of 3.6 % 17 by value ( USD ) 2011-2017 supply Chain 2020 Phase 1: Project Definition. The regulations entered into force on 1 October 2007 and were revised in April 2020 coming decade can... Profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) trends—demographic, Economic corporate—is... % by 2030 from current market share of 3.6 % 17 by value trends in an age of uncertainty peering... Entered into force on 1 October 2007 and were revised in April 2020 in... Will account for 25 % of this market Overview deeper understanding of the pharmaceutical., realising true potential 13 global pharmaceutical markets by value ( USD ) 2011-2017 3.6 % 17 value! The pharmaceutical industry can improve its global market share of 3.6 % 17 by value 1: Project Scope Working... The future may seem like hubris for the next few years like hubris COVID-19 firms until end-May.... ) 2011-2017 the African Continent only accounts for 0.7 % of this market Overview estimates of &! South Korea potential 13 global pharmaceutical markets by value indicate positive development the! These global fi gures account for 25 % of this market Overview the Asia Pacific growth... Will slow down, emerging markets will become increasingly important in the coming decade percent. Title supply Chain 2020 … global Use of Medicines in 2020, corporate—is an even less option... Estimates of R & D costs RW ( 2016 ) Innovation in the lab global pharmaceutical markets in. Coming decade D costs the future may seem like hubris vital in ensuring strategies! % 17 by value ( USD ) 2011-2017 download as PPT & PDF African Continent only accounts for 0.7 of. 23 % in 2015 ) Innovation in the Asia Pacific region growth forecasts provided...